Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Raymond James Financial | B3 | Financials | Investment Banking & Investment Services | 58.7% | R$204.29B | 16.4x | 0.56 | R$479.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Discover Fin | B3 | Financials | Banking Services | 39.1% | R$291.38B | 11.3x | 0.17 | R$580 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Broadcom | B3 | Technology | Semiconductors & Semiconductor Equipment | 24.4% | R$6.29T | 182.1x | -2.73 | R$18.98 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Facebook BDR | B3 | Technology | Software & IT Services | 22.4% | R$10.48T | 29.1x | 0.48 | R$148.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nomura Holdings | B3 | Financials | Investment Banking & Investment Services | 19.3% | R$116.94B | 9.8x | 0.05 | R$39.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jefferies Fin | B3 | Financials | Investment Banking & Investment Services | 18% | R$88.45B | 24.2x | 0.13 | R$431.63 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Workday | B3 | Technology | Software & IT Services | 16.5% | R$419.89B | 45.4x | 0.02 | R$98.87 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Expedia Group | B3 | Consumer Cyclicals | Hotels & Entertainment Services | 13% | R$151.40B | 22.6x | 0.31 | R$597.64 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Goldman Sachs Group BDR | B3 | Financials | Investment Banking & Investment Services | 12.9% | R$1.27T | 15.8x | 0.21 | R$125.90 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Visa Inc BDR | B3 | Technology | Software & IT Services | 12.1% | R$3.94T | 33.2x | 2.43 | R$101 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Charles Schwab BDR | B3 | Financials | Investment Banking & Investment Services | 12% | R$857.24B | 27.7x | 1.57 | R$60.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca | B3 | Healthcare | Pharmaceuticals | 11.4% | R$1.31T | 32.1x | 1.75 | R$69.79 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Morgan Stanley Bank AG | B3 | Financials | Investment Banking & Investment Services | 9.5% | R$1.28T | 17x | 0.33 | R$159.43 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MasterCard Inc BDR | B3 | Technology | Software & IT Services | 8.3% | R$2.99T | 40.5x | 2.29 | R$105.03 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eli Lilly and Co BDR | B3 | Healthcare | Pharmaceuticals | 6.4% | R$4.52T | 73.9x | 0.73 | R$166.79 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intercontinental Exchange | B3 | Financials | Investment Banking & Investment Services | 5.6% | R$553.82B | 34.9x | 2.47 | R$481.69 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bristol Myers Squibb Company BDR | B3 | Healthcare | Pharmaceuticals | 5.2% | R$642.15B | -13x | 0.06 | R$327.03 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prologis | B3 | Real Estate | Residential & Commercial REITs | 3.2% | R$638.34B | 29.6x | 1.34 | R$57.25 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Salesforce.com DRC | B3 | Technology | Software & IT Services | 2.8% | R$1.82T | 53.4x | 0.4 | R$86.68 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Airbnb | B3 | Technology | Software & IT Services | 1.8% | R$488.15B | 46.6x | -0.7 | R$38.93 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences DRC | B3 | Healthcare | Pharmaceuticals | 1.7% | R$686.36B | 944.2x | -9.7 | R$282.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Booking | B3 | Consumer Cyclicals | Hotels & Entertainment Services | 1.3% | R$953.46B | 33.5x | 11.02 | R$163.79 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ServiceNow DRC SA | B3 | Technology | Software & IT Services | 0.2% | R$1.22T | 145.1x | -7.77 | R$117.04 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hess | B3 | Energy | Oil & Gas | 0% | R$254.85B | 16.2x | 0.17 | R$379.24 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novartis AG DRC SA | B3 | Healthcare | Pharmaceuticals | -4.3% | R$1.22T | 18.1x | -1.02 | R$61.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Diamondback | B3 | Energy | Oil & Gas | -9.4% | R$271.24B | 9.3x | -8.05 | R$466.44 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nvidia | B3 | Technology | Semiconductors & Semiconductor Equipment | -11.3% | R$18.98T | 50.2x | 0.22 | R$16.13 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adobe | B3 | Technology | Software & IT Services | -11.6% | R$1.14T | 36.2x | 7.42 | R$51.99 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck Co Inc BDR | B3 | Healthcare | Pharmaceuticals | -14.1% | R$1.28T | 13x | 0 | R$63.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intuit | B3 | Technology | Financial Technology (Fintech) & Infrastructure | -14.7% | R$941.86B | 55.5x | 4.44 | R$76.33 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk AS | B3 | Healthcare | Pharmaceuticals | -20% | R$2.20T | 27.3x | 1.28 | R$62.21 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |